Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Novo Nordisk Inc.
FDA Inspection
•Novo Nordisk Inc.•April 13, 2017

Novo Nordisk Inc. – FDA Inspection, Apr 13, 2017

Record Details

This FDA Inspection record concerns Novo Nordisk Inc., with an inspection on April 13, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Novo Nordisk Inc.
Inspection Date
April 13, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Michael Serrano (Company Rep)
  • Shirley S. Wen (Issuing Officer)
View Company Profile

ID · 1d5c8257-f349-440a-9ebf-72db3b05a4f4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1013344
FDA center
Human Drugs
Project area
Bioresearch Monitoring
Outcome
Form 483 issued

FDA Citations

1
  1. 21 CFR 312.50General responsibilities of sponsors

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Novo Nordisk Inc.

10
DateClassificationOfficeProject area
February 7, 2025OAIBioresearch Monitoring
December 21, 2022NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
June 8, 2017Not classifiedNew Jersey District Office
July 22, 2016NAICenter for Devices and Radiological HealthPostmarket Assurance: Devices
April 12, 2016NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 10 other inspections on the company page
Other documents for Novo Nordisk Inc.
  • FDA Inspection 1255957 - 2025-02-07
  • FDA Inspection 1194065 - 2022-12-21
  • FDA Inspection 1018484 - 2017-06-08
  • FDA Inspection 983531 - 2016-07-22
  • FDA Inspection 968597 - 2016-04-12

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novo Nordisk Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.